Prognostic Value of T-wave Positivity in Lead aVR in COVID-19 Pneumonia

SUMMARY OBJECTIVE: T-wave positivity in the lead aVR is a marker of ventricular repolarization abnormality and provides information on short- and long-term cardiovascular mortality in heart failure patients, those with anterior myocardial infarction, and patients who underwent hemodialysis for various reasons. The aim of this study was to investigate the relationship between T-wave positivity in the lead aVR on superficial electrocardiogram and mortality from COVID-19 pneumonia. METHODS: This study retrospectively included 130 patients who were diagnosed with COVID-19 and treated as an outpatient or in the thoracic diseases ward in a single center between January 2021 and June 2021. All patients included in the study had clinical and radiological features and signs of COVID-19 pneumonia. The COVID-19 diagnosis of all patients was confirmed by polymerase chain reaction detected from an oropharyngeal swab. RESULTS: A total of 130 patients were included in this study. Patients were divided into two groups: survived and deceased. There were 55 patients (mean age: 64.76–14.93 years, 58.18 male, 41.12% female) in the survived group and 75 patients (mean age: 65–15 years, 58.67 male, 41.33% female) in the deceased group. The univariate and multivariate regression analyses showed that positive transcatheter aortic valve replacement (OR 5.151; 95%CI 1.001–26.504; p=0.0012), lactate dehydrogenase (OR 1.006; 95%CI 1.001–1.010; p=0.012), and d-dimer (OR 1.436; 95%CI 1.115–1.848; p=0.005) were independent risk factors for mortality. CONCLUSION: A positive transcatheter aortic valve replacement is useful in risk stratification for mortality from COVID-19 pneumonia.

Saved in:
Bibliographic Details
Main Authors: Sivri,Fatih, Özdemir,Burcu, Çelik,Mehmet Murat, Aksoy,Fatih, Akçay,Burakhan
Format: Digital revista
Language:English
Published: Associação Médica Brasileira 2022
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022000700882
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0104-42302022000700882
record_format ojs
spelling oai:scielo:S0104-423020220007008822022-10-17Prognostic Value of T-wave Positivity in Lead aVR in COVID-19 PneumoniaSivri,FatihÖzdemir,BurcuÇelik,Mehmet MuratAksoy,FatihAkçay,Burakhan Electrocardiographic SARS-CoV-2 Mortality SUMMARY OBJECTIVE: T-wave positivity in the lead aVR is a marker of ventricular repolarization abnormality and provides information on short- and long-term cardiovascular mortality in heart failure patients, those with anterior myocardial infarction, and patients who underwent hemodialysis for various reasons. The aim of this study was to investigate the relationship between T-wave positivity in the lead aVR on superficial electrocardiogram and mortality from COVID-19 pneumonia. METHODS: This study retrospectively included 130 patients who were diagnosed with COVID-19 and treated as an outpatient or in the thoracic diseases ward in a single center between January 2021 and June 2021. All patients included in the study had clinical and radiological features and signs of COVID-19 pneumonia. The COVID-19 diagnosis of all patients was confirmed by polymerase chain reaction detected from an oropharyngeal swab. RESULTS: A total of 130 patients were included in this study. Patients were divided into two groups: survived and deceased. There were 55 patients (mean age: 64.76–14.93 years, 58.18 male, 41.12% female) in the survived group and 75 patients (mean age: 65–15 years, 58.67 male, 41.33% female) in the deceased group. The univariate and multivariate regression analyses showed that positive transcatheter aortic valve replacement (OR 5.151; 95%CI 1.001–26.504; p=0.0012), lactate dehydrogenase (OR 1.006; 95%CI 1.001–1.010; p=0.012), and d-dimer (OR 1.436; 95%CI 1.115–1.848; p=0.005) were independent risk factors for mortality. CONCLUSION: A positive transcatheter aortic valve replacement is useful in risk stratification for mortality from COVID-19 pneumonia.info:eu-repo/semantics/openAccessAssociação Médica BrasileiraRevista da Associação Médica Brasileira v.68 n.7 20222022-07-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022000700882en10.1590/1806-9282.20211096
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Sivri,Fatih
Özdemir,Burcu
Çelik,Mehmet Murat
Aksoy,Fatih
Akçay,Burakhan
spellingShingle Sivri,Fatih
Özdemir,Burcu
Çelik,Mehmet Murat
Aksoy,Fatih
Akçay,Burakhan
Prognostic Value of T-wave Positivity in Lead aVR in COVID-19 Pneumonia
author_facet Sivri,Fatih
Özdemir,Burcu
Çelik,Mehmet Murat
Aksoy,Fatih
Akçay,Burakhan
author_sort Sivri,Fatih
title Prognostic Value of T-wave Positivity in Lead aVR in COVID-19 Pneumonia
title_short Prognostic Value of T-wave Positivity in Lead aVR in COVID-19 Pneumonia
title_full Prognostic Value of T-wave Positivity in Lead aVR in COVID-19 Pneumonia
title_fullStr Prognostic Value of T-wave Positivity in Lead aVR in COVID-19 Pneumonia
title_full_unstemmed Prognostic Value of T-wave Positivity in Lead aVR in COVID-19 Pneumonia
title_sort prognostic value of t-wave positivity in lead avr in covid-19 pneumonia
description SUMMARY OBJECTIVE: T-wave positivity in the lead aVR is a marker of ventricular repolarization abnormality and provides information on short- and long-term cardiovascular mortality in heart failure patients, those with anterior myocardial infarction, and patients who underwent hemodialysis for various reasons. The aim of this study was to investigate the relationship between T-wave positivity in the lead aVR on superficial electrocardiogram and mortality from COVID-19 pneumonia. METHODS: This study retrospectively included 130 patients who were diagnosed with COVID-19 and treated as an outpatient or in the thoracic diseases ward in a single center between January 2021 and June 2021. All patients included in the study had clinical and radiological features and signs of COVID-19 pneumonia. The COVID-19 diagnosis of all patients was confirmed by polymerase chain reaction detected from an oropharyngeal swab. RESULTS: A total of 130 patients were included in this study. Patients were divided into two groups: survived and deceased. There were 55 patients (mean age: 64.76–14.93 years, 58.18 male, 41.12% female) in the survived group and 75 patients (mean age: 65–15 years, 58.67 male, 41.33% female) in the deceased group. The univariate and multivariate regression analyses showed that positive transcatheter aortic valve replacement (OR 5.151; 95%CI 1.001–26.504; p=0.0012), lactate dehydrogenase (OR 1.006; 95%CI 1.001–1.010; p=0.012), and d-dimer (OR 1.436; 95%CI 1.115–1.848; p=0.005) were independent risk factors for mortality. CONCLUSION: A positive transcatheter aortic valve replacement is useful in risk stratification for mortality from COVID-19 pneumonia.
publisher Associação Médica Brasileira
publishDate 2022
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022000700882
work_keys_str_mv AT sivrifatih prognosticvalueoftwavepositivityinleadavrincovid19pneumonia
AT ozdemirburcu prognosticvalueoftwavepositivityinleadavrincovid19pneumonia
AT celikmehmetmurat prognosticvalueoftwavepositivityinleadavrincovid19pneumonia
AT aksoyfatih prognosticvalueoftwavepositivityinleadavrincovid19pneumonia
AT akcayburakhan prognosticvalueoftwavepositivityinleadavrincovid19pneumonia
_version_ 1756410185295855616